During MS, the expression of S1P1, S1P3 and S1P5 on reactive astrocytes is increased [15, 52] [53], prompting several groups to investigate the effects that S1P modulation could exert in inflammatory conditions. This evidence concerns the gene S1PR3 and myeloid sarcoma.